~~<i id='3506DDF50F'><strike id='3506DDF50F'><tt id='3506DDF50F'><pre id='3506DDF50F'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

entertainment

author：focus 2025-10-01 22:49:44 - browse：19979

A close up photograph of an IV drop in a Portland hospital – politics and policy coverage from STAT — A patient receives an IV drip at a hospital in Portland, Ore. Jenny Kane/AP

WASHINGTON — A new White House task force on drug shortages held a rare in-person meeting last Friday with representatives from hospitals, drugmakers, pharmacies, and others in the drug supply chain to brainstorm policies for stemming shortages of cancer drugs.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

focus

hotspot

knowledge

AdobeAsaboygrowingupwithhemophiliaA,NoahFrederickreservedtheendofhisannualcheckupstotalkaboutnewtech

WSS

Focused ultrasound for uterine fibroids: an uphill battle

How many hemophilia patients actually want gene therapy?

Boston's new lab space is opening empty

WuXi out of biotech trade group, U.S. and China relations to blame

Male and female sex labels in research insufficient, scientists say

Male and female sex labels in research insufficient, scientists say

explore

entertainment

focus

Guidelines to prevent youth baseball injuries need more muscle

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

Dobbs anniversary: the lost opportunity of abortion as health care

Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

At least 13 dead in Texas as scorching temps continue

First Opinion Podcast: What happens when kids become caregivers?

Supreme Court strikes down use of affirmative action

EPA limits use of carcinogenic gas for sterilizing medical devices

Wildfire smoke exposes gaps in outdoor worker protections

Adam's Biotech Scorecard: Do Sarepta's exon

hotspot

WuXi out of biotech trade group, U.S. and China relations to blame

Why depression after traumatic brain injury is distinct

Amid AI frenzy, a top HHS official's quest to create safeguards

Report: NIH

First U.S. drug developed to treat liver disease MASH is approved

Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

hotspot

hotspot

hotspot

knowledge